1. Home
  2. SLN vs FLXS Comparison

SLN vs FLXS Comparison

Compare SLN & FLXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silence Therapeutics Plc American Depository Share

SLN

Silence Therapeutics Plc American Depository Share

HOLD

Current Price

$7.13

Market Cap

236.2M

Sector

Health Care

ML Signal

HOLD

Logo Flexsteel Industries Inc.

FLXS

Flexsteel Industries Inc.

HOLD

Current Price

$55.98

Market Cap

224.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLN
FLXS
Founded
1994
2001
Country
United Kingdom
United States
Employees
116
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Home Furnishings
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
236.2M
224.1M
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
SLN
FLXS
Price
$7.13
$55.98
Analyst Decision
Buy
Strong Buy
Analyst Count
5
1
Target Price
$42.60
$54.00
AVG Volume (30 Days)
303.7K
46.9K
Earning Date
05-07-2026
04-20-2026
Dividend Yield
N/A
1.41%
EPS Growth
N/A
N/A
EPS
N/A
3.63
Revenue
N/A
$441,073,000.00
Revenue This Year
N/A
$4.51
Revenue Next Year
N/A
$4.89
P/E Ratio
N/A
$14.86
Revenue Growth
N/A
N/A
52 Week Low
$4.19
$29.38
52 Week High
$8.40
$59.95

Technical Indicators

Market Signals
Indicator
SLN
FLXS
Relative Strength Index (RSI) 51.08 59.38
Support Level $5.91 $52.40
Resistance Level $7.21 $59.23
Average True Range (ATR) 0.47 2.69
MACD -0.11 -0.09
Stochastic Oscillator 34.77 67.72

Price Performance

Historical Comparison
SLN
FLXS

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

About FLXS Flexsteel Industries Inc.

Flexsteel Industries Inc is a United States-based company that manufactures, imports, and markets residential upholstered wooden furniture products. Its product offerings include sofas, loveseats, chairs, rockers, desks, tables, convertible bedding units, and bedroom furniture. The company's products are intended for use in home, office, hotel, healthcare, and other contract applications. A featured component in the company's upholstered furniture is the durable Blue Steel Spring. It operates in the business segment of Furniture products. The company's furniture products business involves the distribution of manufactured and imported products for residential markets.

Share on Social Networks: